Connect your AI

ADMA Biologics ADMA Accrued Compensation

Accrued Compensation at other companies

TG TherapeuticsTGTX

$18.66M+263%

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:AccruedSalariesCurrent.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's accrued compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ADMA Biologics's accrued compensation?: ADMA Biologics (ADMA) reported accrued compensation of $5.45M in Q1 2026.
How has ADMA Biologics's accrued compensation changed year-over-year?: ADMA Biologics's accrued compensation increased by 183.4% year-over-year, from $1.92M to $5.45M.
What is the long-term trend for ADMA Biologics's accrued compensation?: Over 5 years (2020 to 2025), ADMA Biologics's accrued compensation has grown at a 1.9% compound annual growth rate (CAGR), from $734.97K to $809K.
What does accrued compensation mean?: Employee wages, salaries, bonuses, commissions, and benefits earned but not yet paid as of the reporting date.